Get Vaccinated Report Abuse/Neglect Sign up for E-news! Reproductive Health 988: 24/7 LIfeline
NMDOH Logo
Home Resources Federal Government
RSS Feed Icon

Federal Government Resources

Links to federal government agency and organization websites.


CDC Interim Guidance for Collecting, Handling, and Testing Clinical Specimens from Patients Under Investigation (PUIs) for 2019 Novel Coronavirus

CDC Interim Guidance for Collecting, Handling, and Testing Clinical Specimens from Patients Under Investigation (PUIs) for 2019 Novel Coronavirus

CDC Interim Guidance for Collecting, Handling, and Testing Clinical Specimens from Patients Under Investigation (PUIs) for 2019 Novel Coronavirus

Health care providers should contact their local/state health department immediately to notify them of patients with fever and lower respiratory illness who traveled to Wuhan, China within 14 days of symptom onset. Local and state public health staff will determine if the patient meets the criteria for a patient under investigation (PUI) for 2019 Novel Coronavirus (2019-nCoV).

CDC Interim Guidance for Emergency Medical Services (EMS) Systems

CDC Interim Guidance for Emergency Medical Services (EMS) Systems

CDC Interim Guidance for Emergency Medical Services (EMS) Systems

This guidance applies to all first responders, including law enforcement, fire services, emergency medical services, and emergency management officials, who anticipate close contact with persons with confirmed or possible COVID-19 in the course of their work.

CDC Interim Guidance for Healthcare Infection Prevention and Control

CDC Interim Guidance for Healthcare Infection Prevention and Control

CDC Interim Guidance for Healthcare Infection Prevention and Control

Infection control procedures including administrative rules and engineering controls, environmental hygiene, correct work practices, and appropriate use of personal protective equipment (PPE) are all necessary to prevent infections from spreading during healthcare delivery.

CDC Interim Guidance for Healthcare Professionals

CDC Interim Guidance for Healthcare Professionals

CDC Interim Guidance for Healthcare Professionals

Limited information is available to characterize the spectrum of clinical illness associated with 2019-nCoV. No vaccine or specific treatment for 2019-nCoV infection is available; care is supportive.

CDC Interim Guidance for Implementing Home Care of People Not Requiring Hospitalization for 2019 Novel Coronavirus

CDC Interim Guidance for Implementing Home Care of People Not Requiring Hospitalization for 2019 Novel Coronavirus

CDC Interim Guidance for Implementing Home Care of People Not Requiring Hospitalization for 2019 Novel Coronavirus

This interim guidance is for staff at local and state health departments, infection prevention and control professionals, and healthcare personnel who are coordinating the home care and isolation of people with confirmed or suspected 2019-nCoV infection, including patients under investigation.

CDC Interim Guidance for Risk Assessment and Public Health Management of Persons with Potential 2019 Novel Coronavirus Exposure in Travel-associated or Community Settings

CDC Interim Guidance for Risk Assessment and Public Health Management of Persons with Potential 2019 Novel Coronavirus Exposure in Travel-associated or Community Settings

CDC Interim Guidance for Risk Assessment and Public Health Management of Persons with Potential 2019 Novel Coronavirus Exposure in Travel-associated or Community Settings

This interim guidance is effective as of February 3, 2020, and does not apply retrospectively to people who have been in China during the previous 14 days and are already in the United States.

CDC Interim Laboratory Biosafety Guidelines for Handing and Processing Specimens Associated with 2019 Novel Coronavirus

CDC Interim Laboratory Biosafety Guidelines for Handing and Processing Specimens Associated with 2019 Novel Coronavirus

CDC Interim Laboratory Biosafety Guidelines for Handing and Processing Specimens Associated with 2019 Novel Coronavirus

To date, we do not fully understand the pathogenic potential and transmission dynamics of 2019 Novel Coronavirus (2019-nCoV). Until more information becomes available, precautions should be taken in collecting and handling specimens that may contain 2019-nCoV.

CDC Measles (Rubeola)

CDC Measles (Rubeola)

CDC Measles (Rubeola)

This page on the Center for Disease Control and Prevention page has information about Measles Outbreaks, signs and symptoms, and vaccinations.

CDC Media Guidance

CDC Media Guidance

CDC Media Guidance

CDC Media Guidance

CDC Mosquito Control Potential Range in the US

CDC Mosquito Control Potential Range in the US

CDC Mosquito Control Potential Range in the US

This is the CDC page on Estimated potential range of Aedes aegypti and Aedes albopictus in the United States, 2017.

CDC Official Health Advisory - Outbreak of Hepatitis A Virus Infections

CDC Official Health Advisory - Outbreak of Hepatitis A Virus Infections

CDC Official Health Advisory - Outbreak of Hepatitis A Virus Infections

This page on the CDC website is an official Health Advisory regarding the outbreak of Hepatitis A Virus Infections among persons who use drugs and persons experiencing homelessness. This advisory was distributed via the CDC Health Alert Network June 11, 2018.

CDC official heart disease webpage

CDC official heart disease webpage

CDC official heart disease webpage

In the United States, the most common type of heart disease is coronary artery disease (CAD), which can lead to heart attack. You can greatly reduce your risk for CAD through lifestyle changes and, in some cases, medication.

« First | Prev | 5 | 6 | 7 | 8 | 9 | 10 | 11 | Next | Last »